🌐 The GLP-1 and NAD+ Model: A Comprehensive Guide to the Next-Generation Health Subscription

This guide outlines the critical components, operational strategies, and regulatory framework necessary to launch and scale a successful subscription platform offering prescription weight loss (GLP-1 agonists) and longevity support (NAD+).

1. Strategic Positioning: The Dual Value Proposition

Your service is defined by offering two distinct, yet complementary, high-value pathways under a single, unified brand focused on optimization.

The Brand Promise: We offer a clinically supervised, two-pronged approach to health: GLP-1 for weight loss and metabolic reset, paired with NAD+ for sustained energy, recovery, and anti-aging benefits.

2. The Service Offering & Patient Journey

🅰. The GLP-1 Program (Weight Loss)

The operational flow must prioritize clinical safety and patient retention.

1. Medical Intake: Detailed asynchronous questionnaire followed by a synchronous (live video) consultation with a licensed medical provider.
   • Mandatory Requirements: Comprehensive health history, lab work (e.g., lipid panel, HbA1c, thyroid function), and documentation of BMI thresholds as required by state law.
2. Prescription & Fulfillment:
   • Branded vs. Compounded: Decide your strategy. Using compounded GLP-1 (often Semaglutide/Tirzepatide with B12) offers a lower cash price ($100-$500/month), higher margin, and bypasses shortages, but carries higher regulatory risk and liability. Branded prescriptions (Wegovy, Zepbound) require navigating complex insurance (Prior Authorization) and have lower margins but higher perceived safety.
   • Dose Escalation: A scheduled titration plan managed entirely within the subscription (e.g., a 12-month timeline for dosage increases).
   • Delivery: Cold-chain logistics for injectable GLP-1s, shipped monthly from a partner 503A or 503B pharmacy.
3. Adherence & Support (The Subscription Stickiness):
   • Coaching: Mandatory or tiered access to Registered Dietitians or Health Coaches to address nutrition, exercise, and behavior change (crucial for long-term weight maintenance and reducing high discontinuation rates).
   • Check-ins: Automated check-ins and quarterly virtual follow-ups with the prescribing physician for monitoring side effects and adjusting the plan.

🅱. The NAD+ Program (Longevity)

This pillar leverages premium products and delivery methods to drive high Average Revenue Per User (ARPU).

1. NAD+ Delivery Method Strategy:
   • Oral Supplements (NMN/NR): The simplest and most scalable model. High margin, low friction, shipped monthly. Requires sourcing high-purity, third-party tested ingredients.
   • NAD+ Injections (Subcutaneous/IM): More effective absorption than oral. Requires a prescription and training the patient on self-administration, or partnering with local injection/IV clinics.
   • NAD+ IV Drips: The most expensive, highest bioavailability, and highest ARPU model. Requires establishing a physical clinic network or robust partnerships with mobile IV services.
2. Personalization: Base NAD+ product dosage/format on patient goals and, ideally, baseline biomarker testing (e.g., cellular NAD+ level tests, if incorporated into the subscription).
3. Pricing: Position NAD+ as the premium longevity fuel, bundling it with the GLP-1 subscription at an elevated tier.

3. Business Model & Pricing

Your model must cover the high costs of prescriptions, fulfillment, and clinical oversight.

Tiered Subscription Example

*Note on GLP-1 Cost: This price range typically assumes using compounded GLP-1. If using branded, FDA-approved GLP-1s, the subscription fee may only cover the membership/service, with the patient responsible for the separate, higher drug cost (usually $800 – $1,300/month).

4. Operational Pillars

💻 Technology Platform

• EHR & E-Prescribing: Must be HIPAA-compliant and seamlessly integrated.
• Patient Dashboard: Must visualize data for both pillars: Weight loss (progress, side effects) and Longevity (energy scores, biomarker trends).
• Logistics & Inventory: Seamless integration with partner pharmacies for automated refills, cold-chain shipping tracking, and managing supplement inventory.

⚖️ Regulatory & Legal Compliance (Crucial)

The regulatory environment is rapidly evolving, particularly for GLP-1s.

• Valid Patient-Physician Relationship: Most states require a synchronous (live video or in-person) consultation to establish care, especially for high-risk prescription drugs like GLP-1s. Avoid relying on asynchronous (form-only) visits.
• Compounding Scrutiny: The FDA has issued repeated warnings regarding compounded GLP-1s. Your legal team must ensure your partner compounding pharmacy is reputable (503A/503B) and that prescriptions meet the “medically necessary” criteria for the individual patient, especially if using compounded mixtures with additives like B12.
• Physician Licensing: Ensure your network of prescribing physicians is licensed in all states where you plan to serve patients.
• Prescribing Standards: Adhere strictly to state-specific requirements for prescribing weight-loss medication (e.g., minimum BMI thresholds, required follow-up frequency).

5. Risk Mitigation & Long-Term Strategy

• Clinical Safety First: Aggressively monitor for GLP-1 side effects (e.g., gastrointestinal issues, gastroparesis) and have clear escalation protocols for serious adverse events.
• Data Validation: While NAD+ benefits are compelling, their use in this setting is largely considered “wellness.” Ensure marketing is clear and evidence-based, especially when making longevity claims.
• The Insurance Shift: Be prepared for market disruption. If branded GLP-1s become widely covered by commercial insurance, the compounded cash-pay model will face heavy price pressure. Your long-term moat will be the coaching, continuous care, and longevity component (NAD+).